Companion Animals

Dog Lymphoma Treatment and Quality of Life

Canine lymphoma is the most common haematopoietic tumour in dogs, with chemotherapy achieving remission in many cases, but quality of life considerations during treatment are essential.

Key Facts

Lymphoma accounts for approximately 7% of all canine tumours
CHOP-based chemotherapy protocol achieves remission in 85-90% of high-grade lymphoma cases
Median survival with treatment is 12-13 months for multicentric lymphoma
Dogs generally tolerate chemotherapy better than humans with fewer side effects
Prednisolone alone provides palliative benefit for owners unable to pursue chemotherapy

Welfare Considerations

Lymphoma treatment can provide a year or more of good quality life for many dogs. Quality of life monitoring during treatment is essential to guide continuation decisions.

What You Can Do

Seek oncology specialist consultation at lymphoma diagnosis
Monitor quality of life using validated tools throughout treatment
Discuss prednisolone palliative option if chemotherapy is not pursued
Prepare for monitoring side effects including nausea and infection risk during treatment